Masimo (MASI) FCF Margin Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 943.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -2,196.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -20.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2,679.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -461.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 417.00 |
| 10 | Masimo | 9.32 Bn | 9.20 Bn | 250.80 Mn | 1,196.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 1,196.00 |
| Jan 3, 2026 | 1,626.00 |
| Sep 27, 2025 | 1,306.00 |
| Jun 28, 2025 | 1,684.00 |
| Mar 29, 2025 | 860.00 |
| Dec 28, 2024 | -3,173.00 |
| Mar 30, 2024 | -515.00 |
| Sep 30, 2023 | -1,552.00 |
| Jul 1, 2023 | -1,386.00 |
| Apr 1, 2023 | -342.00 |
| Dec 31, 2022 | -2,677.00 |
| Oct 1, 2022 | -1,749.00 |
| Jul 2, 2022 | -907.00 |
| Apr 2, 2022 | -1,444.00 |
| Jan 1, 2022 | 2,041.00 |
| Apr 3, 2021 | -1,519.00 |
| Sep 26, 2020 | 1,486.00 |
| Jun 27, 2020 | 3,373.00 |
| Mar 28, 2020 | -285.00 |
| Dec 28, 2019 | -15,405.00 |
| Sep 28, 2019 | 137.00 |
| Jun 29, 2019 | -1,101.00 |
| Mar 30, 2019 | 746.00 |
| Dec 29, 2018 | -1,379.00 |
| Mar 31, 2018 | 3,079.00 |
| Sep 30, 2017 | -1,958.00 |
| Jul 1, 2017 | 1,424.00 |
| Apr 1, 2017 | -1,032.00 |
| Dec 31, 2016 | 17,438.00 |
| Oct 1, 2016 | 717.00 |
| Jul 2, 2016 | 1,504.00 |
| Apr 2, 2016 | -925.00 |
| Jan 2, 2016 | 2,826.00 |
| Apr 4, 2015 | -1,666.00 |
| Sep 27, 2014 | -107.00 |
| Jun 28, 2014 | -4,732.00 |
| Mar 29, 2014 | 155.00 |
| Dec 28, 2013 | -2,027.00 |
| Mar 30, 2013 | -1,749.00 |
| Sep 29, 2012 | -104.00 |